The LifeSite Hemodialysis System (Vasca, Inc., Tewksbury, MA, USA)is totally subcutaneous, incorporating two silicone catheters positioned in the central venous system and connected to a stainless ...

Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides no advantage over 5% heparin locks in reducing infections or ...

The effectiveness of alteplase and urokinase in restoring adequate hemodialysis blood-flow rates was examined. A retrospective review of the medical records of hemodialysis patients with central ...

A case involving chronic venous occlusion in a patient with a recently constructed AV loop graft sheds light on the ...

The global central venous catheter market is on a strong upward trajectory, with projections indicating a rise from USD 2,861.0 million in 2024 to a remarkable USD 5,436.8 million by 2034. This growth ...

The product has been designed to significantly reduce the incidence of catheter-related bloodstream infections in adult patients receiving chronic hemodialysis with central venous catheters.